Cipla rises on the buzz of inking pact with Hetero to launch Darbepoetin Alfa in India

19 Jun 2014 Evaluate

Cipla is currently trading at Rs. 427.05, up by 1.90 points or 0.45% from its previous closing of Rs. 425.15 on the BSE.

The scrip opened at Rs. 430.00 and has touched a high and low of Rs. 430.00 and Rs. 419.65 respectively. So far 177870 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 450.00 on 16-Sep-2013 and a 52 week low of Rs. 366.70 on 24-Feb-2014.

Last one week high and low of the scrip stood at Rs. 443.20 and Rs. 407.20 respectively. The current market cap of the company is Rs. 34019.78 crore.

The promoters holding in the company stood at 36.80% while Institutions and Non-Institutions held 34.75% and 27.35% respectively.

Cipla has reportedly entered into agreement with Hetero to launch Darbepoetin Alfa in India. Darbepoetin Alfa is a synthetic form of erythropoietin, clinically proven to stimulate erythropoiesis (increased hemoglobin levels) for patients with anemia due to chronic kidney disease.

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For more than 70 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries.

Cipla Share Price

1494.40 -10.65 (-0.71%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×